| 0 |
CCR5 Co-receptor Antagonist [EPC] |
6 |
0.0026 |
| 1 |
Protease Inhibitor [EPC] |
81 |
0.0018 |
| 2 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
2 |
0.0016 |
| 3 |
Cytochrome P450 3A Inhibitor [EPC] |
85 |
0.0014 |
| 4 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
31 |
0.0013 |
| 5 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
63 |
0.0013 |
| 6 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
119 |
0.0011 |
| 7 |
Antimalarial [EPC] |
6 |
0.0006 |
| 8 |
Antiprotozoal [EPC] |
6 |
0.0006 |
| 9 |
alpha-Hydroxy Acid [EPC] |
1 |
0.0005 |
| 10 |
Sulfone [EPC] |
4 |
0.0004 |
| 11 |
Rifamycin Antimycobacterial [EPC] |
1 |
0.0003 |
| 12 |
Histone Deacetylase Inhibitor [EPC] |
1 |
0.0003 |
| 13 |
Echinocandin Antifungal [EPC] |
2 |
0.0002 |
| 14 |
Antihypoglycemic Agent [EPC] |
1 |
0.0002 |
| 15 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
22 |
0.0002 |
| 16 |
Antimycobacterial [EPC] |
5 |
0.0002 |
| 17 |
Thrombopoietin Receptor Agonist [EPC] |
3 |
0.0002 |
| 18 |
Azole Antifungal [EPC] |
30 |
0.0002 |
| 19 |
Androgen [EPC] |
5 |
0.0002 |
| 20 |
Bismuth [EPC] |
1 |
0.0002 |
| 21 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
4 |
0.0002 |
| 22 |
Interleukin-17A Antagonist [EPC] |
6 |
0.0002 |
| 23 |
Lipid-based Polyene Antifungal [EPC] |
2 |
0.0002 |
| 24 |
Glycopeptide Antibacterial [EPC] |
10 |
0.0002 |
| 25 |
Purine Antimetabolite [EPC] |
14 |
0.0001 |
| 26 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
1 |
0.0001 |
| 27 |
Provitamin D2 Compound [EPC] |
4 |
0.0001 |
| 28 |
Non-narcotic Antitussive [EPC] |
2 |
0.0001 |
| 29 |
Quinolone Antimicrobial [EPC] |
1 |
0.0001 |
| 30 |
Phenothiazine [EPC] |
3 |
0.0001 |
| 31 |
Human Immunoglobulin G [EPC] |
2 |
0.0001 |
| 32 |
CD20-directed Cytolytic Antibody [EPC] |
30 |
0.0001 |
| 33 |
Rifamycin Antibacterial [EPC] |
3 |
0.0001 |
| 34 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
1 |
0.0001 |
| 35 |
Tetracycline-class Drug [EPC] |
5 |
0.0001 |
| 36 |
Oxazolidinone Antibacterial [EPC] |
2 |
0.0001 |
| 37 |
Muscle Relaxant [EPC] |
3 |
0.0001 |
| 38 |
Insulin [EPC] |
3 |
0.0001 |
| 39 |
Anticholinergic [EPC] |
1 |
0.0001 |
| 40 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
1 |
0.0001 |
| 41 |
Anti-epileptic Agent [EPC] |
13 |
0.0001 |
| 42 |
Penem Antibacterial [EPC] |
2 |
0.0001 |
| 43 |
Macrolide Antimicrobial [EPC] |
3 |
0.0001 |
| 44 |
Vitamin D Analog [EPC] |
1 |
0.0001 |
| 45 |
Mood Stabilizer [EPC] |
12 |
0.0001 |
| 46 |
Fluoroquinolone Antibacterial [EPC] |
7 |
0.0001 |
| 47 |
Alkylating Drug [EPC] |
13 |
0.0001 |
| 48 |
Histamine-2 Receptor Antagonist [EPC] |
7 |
0.0001 |
| 49 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
6 |
0.0001 |
| 50 |
CD52-directed Cytolytic Antibody [EPC] |
1 |
0.0001 |
| 51 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
6 |
0.0001 |
| 52 |
Polyene Antifungal [EPC] |
2 |
0.0000 |
| 53 |
Carbonic Anhydrase Inhibitor [EPC] |
1 |
0.0000 |
| 54 |
Vitamin D3 Analog [EPC] |
1 |
0.0000 |
| 55 |
Interleukin-23 Antagonist [EPC] |
5 |
0.0000 |
| 56 |
Thiazide-like Diuretic [EPC] |
2 |
0.0000 |
| 57 |
General Anesthetic [EPC] |
2 |
0.0000 |
| 58 |
Benzodiazepine [EPC] |
31 |
0.0000 |
| 59 |
Aminoglycoside Antibacterial [EPC] |
2 |
0.0000 |
| 60 |
Parathyroid Hormone Analog [EPC] |
5 |
0.0000 |
| 61 |
Bile Acid [EPC] |
1 |
0.0000 |
| 62 |
Interleukin-6 Receptor Antagonist [EPC] |
6 |
0.0000 |
| 63 |
Aluminum Complex [EPC] |
1 |
0.0000 |
| 64 |
Atypical Antipsychotic [EPC] |
18 |
0.0000 |
| 65 |
Topoisomerase Inhibitor [EPC] |
3 |
0.0000 |
| 66 |
Corticosteroid [EPC] |
50 |
0.0000 |
| 67 |
PCSK9 Inhibitor [EPC] |
1 |
0.0000 |
| 68 |
Interleukin-12 Antagonist [EPC] |
4 |
0.0000 |
| 69 |
Alkaloid [EPC] |
1 |
0.0000 |
| 70 |
Opioid Agonist [EPC] |
10 |
0.0000 |
| 71 |
Nucleoside Analog Antiviral [EPC] |
3 |
0.0000 |
| 72 |
Integrin Receptor Antagonist [EPC] |
3 |
0.0000 |
| 73 |
Cholinergic Nicotinic Agonist [EPC] |
2 |
0.0000 |
| 74 |
Folate Analog Metabolic Inhibitor [EPC] |
14 |
0.0000 |
| 75 |
Sympathomimetic-like Agent [EPC] |
1 |
0.0000 |
| 76 |
Nitroimidazole Antimicrobial [EPC] |
2 |
0.0000 |
| 77 |
Aminosalicylate [EPC] |
3 |
0.0000 |
| 78 |
Prostacycline Vasodilator [EPC] |
4 |
0.0000 |
| 79 |
Xanthine Oxidase Inhibitor [EPC] |
5 |
0.0000 |
| 80 |
Cholinergic Muscarinic Antagonist [EPC] |
1 |
0.0000 |
| 81 |
Loop Diuretic [EPC] |
11 |
0.0000 |
| 82 |
Proton Pump Inhibitor [EPC] |
14 |
0.0000 |
| 83 |
Vitamin D [EPC] |
7 |
0.0000 |
| 84 |
Nitrate Vasodilator [EPC] |
2 |
0.0000 |
| 85 |
Phosphodiesterase 5 Inhibitor [EPC] |
3 |
0.0000 |
| 86 |
Vitamin B12 [EPC] |
7 |
0.0000 |
| 87 |
alpha-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 88 |
Dihydropyridine Calcium Channel Blocker [EPC] |
7 |
0.0000 |
| 89 |
beta3-Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 90 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
1 |
0.0000 |
| 91 |
Interferon beta [EPC] |
4 |
0.0000 |
| 92 |
5-alpha Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 93 |
Aldosterone Antagonist [EPC] |
3 |
0.0000 |
| 94 |
Vitamin C [EPC] |
8 |
0.0000 |
| 95 |
Erythropoiesis-stimulating Agent [EPC] |
1 |
0.0000 |
| 96 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
23 |
0.0000 |
| 97 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 98 |
Platelet Aggregation Inhibitor [EPC] |
9 |
0.0000 |
| 99 |
Insulin Analog [EPC] |
7 |
0.0000 |
| 100 |
Tumor Necrosis Factor Blocker [EPC] |
15 |
0.0000 |
| 101 |
Endothelin Receptor Antagonist [EPC] |
3 |
0.0000 |
| 102 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
2 |
0.0000 |
| 103 |
Kinase Inhibitor [EPC] |
8 |
0.0000 |
| 104 |
Potassium Channel Blocker [EPC] |
1 |
0.0000 |
| 105 |
Cardiac Glycoside [EPC] |
1 |
0.0000 |
| 106 |
Osmotic Laxative [EPC] |
4 |
0.0000 |
| 107 |
Androgen Receptor Inhibitor [EPC] |
1 |
0.0000 |
| 108 |
HER2/neu Receptor Antagonist [EPC] |
1 |
0.0000 |
| 109 |
Catecholamine [EPC] |
1 |
0.0000 |
| 110 |
Histamine-1 Receptor Antagonist [EPC] |
1 |
0.0000 |
| 111 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 112 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1 |
0.0000 |
| 113 |
Partial Opioid Agonist [EPC] |
1 |
0.0000 |
| 114 |
RANK Ligand Inhibitor [EPC] |
2 |
0.0000 |
| 115 |
beta-Adrenergic Blocker [EPC] |
3 |
0.0000 |
| 116 |
Expectorant [EPC] |
2 |
0.0000 |
| 117 |
Antirheumatic Agent [EPC] |
1 |
0.0000 |
| 118 |
P2Y12 Platelet Inhibitor [EPC] |
1 |
0.0000 |
| 119 |
Sulfonylurea [EPC] |
1 |
0.0000 |
| 120 |
Retinoid [EPC] |
2 |
0.0000 |
| 121 |
Thalidomide Analog [EPC] |
4 |
0.0000 |
| 122 |
Factor Xa Inhibitor [EPC] |
2 |
0.0000 |
| 123 |
Selective T Cell Costimulation Modulator [EPC] |
1 |
0.0000 |
| 124 |
Calcium [EPC] |
1 |
0.0000 |
| 125 |
Angiotensin 2 Receptor Blocker [EPC] |
2 |
0.0000 |
| 126 |
Janus Kinase Inhibitor [EPC] |
1 |
0.0000 |
| 127 |
Phosphodiesterase 4 Inhibitor [EPC] |
1 |
0.0000 |
| 128 |
HMG-CoA Reductase Inhibitor [EPC] |
2 |
0.0000 |
| 129 |
Thiazide Diuretic [EPC] |
1 |
0.0000 |
| 130 |
Nucleoside Metabolic Inhibitor [EPC] |
1 |
0.0000 |
| 131 |
Progestin [EPC] |
1 |
0.0000 |
| 132 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |
| 133 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1 |
0.0000 |